/Investor DB

BGV

Venture capitalActively deploying

Silicon Valley · Seed–Late Stage · 10 people tracked

Find your way into BGV

Each arrow is one introduction. Sign up to fill in the first one.

4,107 people can intro you to Ekaterina

Ask Trushna Dave to introduce you to Ekaterina Evchenko

You →Trushna · together at Xcaliber →Ekaterina

509 people can intro you to Yashwanth

Ask Jamie Chen to introduce you to Yashwanth Hemaraj

You →Jamie · together at Arka Venture Labs →Yashwanth

239 people can intro you to Etienne

Ask Sam Okafor to introduce you to Etienne Arsac

You →Sam · together at Deezer →Etienne

Sign up to find every way you can get introduced to BGV

  • Your email: who you already know at BGV, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BGV team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

BGV is a cross-border VC platform rooted in Silicon Valley that backs enterprise-focused B2B technology companies, deploying capital from seed stage to IPO. The firm concentrates on what it calls Enterprise 5.0 companies and cross-border innovation, targeting startups driving leapfrog shifts in enterprise automation and productivity by combining intelligent machines with human ingenuity while emphasizing responsible, human-centric design. Founded by immigrant entrepreneurs-turned-investors, BGV positions itself to provide not only financing but also operational expertise, global resources, and cross-border advisory support to help founders build global B2B technology companies.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Silicon Valley, California, US
Instruments
Equity
Founded
2003
Last 12 months
1 investment
Tracked investments
36
Acquisitions
3

Team · 10 people

from public directories
Patrick Nicolet· Operating Partner

What they invest in

from 30 of 36 portfolio companies

AI & Machine Learning ×18SaaS ×15Enterprise Software ×13Healthtech ×11Biotech ×10Data & Infrastructure ×6Developer Tools ×5Deep Tech ×3

HQs:United States×20United Kingdom×2Netherlands×2Germany×1France×1

Investments · 36 tracked

founders shown can be your intro path

By year:2026 · 12025 · 42023 · 22022 · 32021 · 22020 · 42019 · 12018 · 12016 · 220 dated

Brenigbrenigther.comin𝕏✓ verified

Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.

AI & Machine LearningBiotechHealthtechDover, US

Megan McGill(Chief Executive Officer)inIain Dukes(Chief Business Officer / Chairman of the Board)inNikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)in

Co-investorsNew Enterprise Associates (NEA)OrbiMedTorrey Pines Investment

Dunaddunadtx.comin✓ verified

Dunad Therapeutics is a biotech company developing oral small-molecule medicines using a covalent chemistry discovery platform to target neurodegenerative diseases such as ALS, Parkinson's disease, and FTD.

BiotechDeep TechCambridge, GB

Pearl Huang(President & CEO)inStephen Huhn(CMO)

Co-investorsAlpha Wave GlobalEpidarex Capital

Lyzrlyzr.aiin𝕏✓ verified

Lyzr builds infrastructure and platforms for deploying production-grade AI agents in enterprises, with emphasis on governance, security, observability, and human oversight.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSJersey City, US

Siva Surendira(Founder & CEO)inSurendirasiva Selvaraj(Executive Officer, Director)Jithin George(Founder)in

BoardMadhu Shalini Iyer(Director)inHenry Ford III(Director)

Co-investorsRocketship.vcAccenture VenturesArka Venture LabsBetter CapitalCocoon Ignite VenturesGFT Ventures+3 more

Northsea Therapeuticsnorthseatherapeutics.comin✓ verified

NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH.

BiotechDigital HealthHealthtech

Co-investorsNew Science VenturesvenBio PartnersYsios CapitalNovo HoldingsBioGeneration VenturesSofinnova Ventures+1 more

Terretterret.ai✓ verified

Terret provides a platform for managing revenue operations, designed for sales and go-to-market teams at startups and enterprises.

AI & Machine LearningEnterprise SoftwareSaaSSales Tech

Justin Shriber(Cofounder and CEO)Amit Sasturkar(Cofounder and CTO)

Co-investorsEMERGENT VENTURESNGP Capital

Datawizzdatawizz.aiin𝕏Aug 2025

Gamut is an open-source, self-hostable platform where people and AI agents collaborate in shared threads, with agents that use a real browser, connect to APIs and MCP servers, run on schedules or webhooks, and operate from tools like Slack, Telegram, and iMessage.

AI & Machine LearningFuture of WorkSaaSBerkeley, US

Iddo Gino(Executive Officer, Director, Promoter)Sigal Shaked(Executive Officer, Director)

Board seatEric Buatois· per SEC Form D

Co-investorsBenhamou Global VenturesHuman Capital

MadKudumadkudu.cominDec 2019acquired by HG InsightsSEC filingmedium confidence

AI & Machine LearningEnterprise SoftwareMarketing TechSaaSSales TechMountain View, US

Paul Cothenet(Founder)inAnselme Le Van(Founder)

Board seatEric Buatois· per SEC Form D · $6M raise · filed Jan 2020

Co-investorsMatchstick VenturesPartech VenturesTechstarsBenhamou Global VenturesFelicis Ventures

Onymosonymos.comin𝕏Jan 2020SEC filingmedium confidence

Onymos offers DocKnow, a document and data processing platform for clinical laboratories that captures, validates, and enriches intake documents such as test requisition forms and medical records.

AI & Machine LearningCloud ComputingDeveloper ToolsHealthtechSaaSRedwood Shores, US

SHIVAGURU NATHAN(Executive Officer, Director)Shiva Nathan(Founder & CEO)inShiva N(Founder)Bhavani Vangala(CTO)in

Board seatEric Buatois· per SEC Form D · $2.2M raise · filed Feb 2020

Co-investorsGreatPoint VenturesBenhamou Global VenturesEngineering CapitalIndustry Ventures

Profitectprofitect.comNov 2016SEC filingmedium confidence

Waltham, US

Guy Yehiav(Chief Executive Officer and Director)Niv Krikov(Treasurer and Secretary)

BoardEddy Shalev(Director)Janice M. Roberts(Director)

Board seatEric Buatois· per SEC Form D · $7.2M raise · filed Feb 2017

Co-investorsVertical Venture PartnersBenhamou Global VenturesCedar Fund

Scalefastscalefast.comMar 2018 · $8Macquired by ESW

End-to-end DTC e-commerce platform for high-growth brands (acquired by ESW at a $305M valuation).

E-commerceLogistics & Supply ChainRetail TechSaaSEl Segundo, US

Nicolas Stehle(Executive Officer, Director)inOlivier Schott(Director)inPhilippe Bouissou(Director)

Board seatEric Buatois· per SEC Form D

Co-investorsAdara VenturesBY Venture PartnersFJ LabsXplorer CapitalBenhamou Global VenturesFrench Partners

Anetaaneta.companyMay 2023

Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsPebblebedAndera PartnersForbionFountain Healthcare PartnersHTGFPMV+2 more

Artica Therapeuticsartica-tx.cominNov 2023

Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.

BiotechDeep TechHealthtech

Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in

Co-investorsBioGeneration VenturesThuja CapitalSeroba Life Sciences

Bayshore Networksbayshorenetworks.comacquired by OPSWAT

Cybersecurity for critical infrastructure, ICS and OT (acquired by OPSWAT)

Bethesda, US

Francis Cianfrocca(Director)Bob Lam(Executive Officer)Michael Dager(Executive Officer, Director)

BoardAlberto Yepez(Director)Christopher T Winkler(Director)Anik Bose(Director)in

Co-investorsEvolution Equity PartnersForgePoint CapitalBenhamou Global Ventures

Complement Therapeuticscomplementtx.comFeb 2022

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsBioGeneration VenturesCambridge Innovation CapitalGimvHadean VenturesSeroba Life SciencesForbion+2 more

Constella Intelligenceconstella.aiinOct 2020 · $30M

Constella Intelligence provides Digital Risk Protection solutions that combine proprietary breach data, technology, and human analysis to detect and mitigate digital threats across the surface and dark web.

AI & Machine LearningCybersecurityData & InfrastructureEnterprise SoftwareSaaS

Co-investorsC5 CapitalForgePoint CapitalTheVentureCityAdara VenturesBenhamou Global Ventures

Drishti Technologies, Inc.drishti.comJun 2020 · $25MNo public record

No factual description available; likely a sector classification label rather than a real startup.

Co-investorsPresidio VenturesSozo Ventures

Everest Labseverestlabs.aiin𝕏Sep 2022 · $16.1M

EverestLabs builds RecycleOS, an AI-powered operating system for recycling plants that uses computer vision, AI, and robotics to identify and sort recyclable materials in Material Recovery Facilities (MRFs).

AI & Machine LearningCircular EconomyClimate TechImpact & Social GoodRoboticsFremont, US

JD Ambati(Founder/Chief Strategy Officer)inR Paul Singh(CEO)

Co-investorsSierra VenturesTransLink CapitalUnanimous CapitalXplorer CapitalBenhamou Global VenturesHike Ventures+1 more

Evincedevinced.com

Evinced offers an AI-powered chatbot focused on digital accessibility that answers developer and team questions, reviews code for accessibility issues across web and mobile frameworks, and can read design screenshots.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSPalo Alto, US

Navin R. Thadani(Founder)inGal Moav(Founder)in

Co-investorsBenhamou Global VenturesCapital One VenturesEngineering CapitalInsight PartnersM12 (Microsoft's Venture Fund)Vertex Ventures Israel+1 more

Fiddler AIfiddler.aiin𝕏Jan 2026 · $30M

Fiddler AI provides an AI observability and control platform offering experiments, monitoring, guardrails, and governance for enterprise AI agents and compound AI systems.

AI & Machine LearningData & InfrastructureEnterprise SoftwarePalo Alto, US

Krishna Gade(Founder & CEO)inAmit Paka(Executive Officer, Director)in

BoardRaviraj Jain(Director)inBilal Zuberi(Director)inGeorge Mathew(Director)in

Co-investorsAngel Collective Opportunity FundaVentureBenhamou Global VenturesBloomberg BetaCisco InvestmentsDallas Venture Capital+22 more

i2020 Acceleratori2020accelerator.comin

i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases.

BiotechDeep TechHealthtechSan Diego, US

Co-investorsTorrey Pines InvestmentBioGeneration VenturesOrbiMed

Macrometamacrometa.coin𝕏Oct 2020 · $7M

Macrometa builds a globally distributed cloud platform designed for real-time applications that require high performance and low latency.

AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsE-commerceEnterprise SoftwareRetail TechSaaS

Co-investorsAurum Venture PartnersPartech VenturesVU Venture PartnersBenhamou Global VenturesDnx VenturesPelion Venture Partners+2 more

MindsDBmindsdb.comin𝕏Seed

MindsDB builds open-source infrastructure for AI-augmented analytics and data work, enabling users to interact with their data through natural language.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Adam Carrigan(Founder)inJorge Torres(Founder)in

Co-investorsAngel InvestBerkeley SkyDeck FundMayfield FundMMC VenturesNVenturesOpenOcean+14 more

Otojoinoto.comin𝕏Seed

Oto is a tinnitus management program combining professional audiologist care with a mobile app delivering cognitive behavioral therapy exercises, soundscapes, and mindfulness techniques.

Digital HealthHealthtechWellness & FitnessLondon, GB

Edmund Farrar(Founder)inGeorge Leidig(Founder)in

Co-investorsKickstart InnovationOctopus VenturesRedbus VenturesY CombinatorAcequia Capital (AceCap)Bethnal Green Ventures+3 more

Phlox Therapeuticsphloxtherapeutics.cominMay 2022

Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies.

BiotechHealthtechNaarden, NL

Co-investorsROM Utrecht RegionUvA Ventures Holding

Pyzepyze.com

Pyze provides an Execution Intelligence platform that captures how employees actually work inside web-based enterprise applications, helping organizations measure workforce productivity, find automation opportunities, and evaluate AI agent deployments.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSaaS

Co-investorsAAF Management Ltd.Candou VenturesCorrelation VenturesIlluminate VenturesBenhamou Global VenturesDoubleRock

River BioMedicsriverbiomedics.comin

River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies.

BiotechHealthtechMedical Devices

Robert Passier(Founder)in

Co-investorsBioGeneration VenturesKIKK CapitalOost NL

StyleUpthestyleup.cominSeed

A live sports streaming platform offering HD-quality broadcasts of football matches including Turkish Super Lig, European leagues, and Champions League.

ConsumerDirect to ConsumerMedia & EntertainmentSan Francisco, US

Co-investorsY CombinatorAndreessen HorowitzBatch VenturesIntel CapitalKima VenturesNO LABEL VENTURES+2 more

Tessellate BIOtessellatebio.com

Tessellate Bio is a biotech company researching synthetic lethal interactions beyond Homologous Recombination Deficiency (HRD) to build a pipeline of first-in-class precision medicines.

BiotechHealthtech

Co-investorsBioGeneration VenturesForbion

The Forecasting Companytheforecastingcompany.comin𝕏Seed

A forecasting platform that applies large language model technology to time series prediction for enterprise use cases.

AI & Machine LearningData & InfrastructureEnterprise SoftwareParis, FR

Geoffrey Negiar(Founder & CEO)inJoachim Fainberg(Co-founder & CTO)inGeoffrey Négiar(Co-founder & CEO)in

Co-investorsY CombinatorKima VenturesNO LABEL VENTURESStemAI VCBatch VenturesBenhamou Global Ventures+6 more

Totangototango.cominSep 2021 · $100M

Totango offers a customer success platform for businesses to manage customer relationships and drive revenue retention and growth, including AI-powered features like account summaries and a customer intelligence engine.

AI & Machine LearningEnterprise SoftwareSaaSSales TechSan Mateo, US

Guy Nirpaz(Founder)inTomer Manor(VP Finance)inKeith Frankel(CEO)inSherman Chu(Director)inTomas Carlos Tovar(Director)Nechemia Jacob Peres(Director)

Co-investorsGreat Hill PartnersBenhamou Global VenturesCanvas VenturesGarage CapitalBioGeneration VenturesGemini Israel Ventures+1 more

VarmXvarmx.comin

VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.

BiotechHealthtechMedical Devices

Pieter ReitsmainJohn Glasspool(Chief Executive Officer)in

Co-investorsBioGeneration VenturesInkefSound BioventuresYsios CapitalEICEQT Life Sciences+2 more

Workhelixworkhelix.comin𝕏Feb 2025

Workhelix provides enterprise leaders with real-time visibility into their AI adoption, quantifying time saved, mapping AI opportunities, and linking usage to business outcomes.

AI & Machine LearningEnterprise SoftwareSaaSBeaverton, US

Erik Brynjolfsson(Director)inAndrew McAfee(Director)inDaniel Rock(Director)inShaun Johnson(Director)inJames Milin(Executive Officer, Director)

Co-investorsAI FundAIX VenturesBloomberg BetaAccenture VenturesBenhamou Global VenturesTeleSoft Partners

Zelroszelros.com𝕏Feb 2021 · $11M

Zelros (now part of Earnix) offers an AI decisioning and orchestration system built for insurers, covering pricing, underwriting, and customer engagement across multiple lines of business.

AI & Machine LearningInsurTechSaaS

Co-investors42CAPastorya.vcIsaiISAI GestionBenhamou Global Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

6d bytes inc.NxGn DataNypit

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 3

3 acquisitions

MadKuduacq. by HG InsightsScalefastacq. by ESWBayshore Networksacq. by OPSWAT

Portfolio news

latest coverage across their companies
Trysignalbase

Evinced · trysignalbase.com · Jul 14, 2026

Datawizz Raises $12.5M Seed Funding

Datawizz · finsmes.com · Sep 30, 2025

Frequently asked questions

How many investments has BGV made?
BGV has 36 tracked investments, 3 of which have exited, including 5 dated in the last 24 months.
What stage does BGV invest at?
BGV invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does BGV focus on?
BGV focuses on AI & Machine Learning, Data & Infrastructure, Enterprise Software, Robotics, SaaS, Semiconductors.
Where is BGV located?
BGV is headquartered in Silicon Valley, US.

Media · Podcasts & interviews

featuring the team

Interview with BlockStars: Yashwanth Hemaraj, BGV General Partner

Benhamou Global Ventures · Yashwanth Hemaraj

VC Strategy, with Yashwanth Hemaraj Partner at BGV | Episode #4

The Blueprint Podcast · Yashwanth Hemaraj

Keynote - Eric Benhamou (Founder, BGV) | Arka Spring Showcase '21

Arka Venture Labs · Eric Benhamou

They are Innovation - Eric BENHAMOU - Founder & Managing Director BGV | Videos & Películas en Vimeo

BLUMORPHO · Eric Benhamou · vimeo.com

IFG Network Testimonial- Anik Bose BGV - Benhamou Global Ventures on Vimeo

marcus evans summit marketing · Anik Bose · vimeo.com

IFG Network Testimonial: Anik Bose, BGV - Benhamou Global Ventures | Videos & Movies on Vimeo

IFG Network · Anik Bose · vimeo.com

Images

BGV photo

Similar investors

Featured in lists